RTH258 (brolucizumab)

brolucizumab · Alcon Research Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RTH258 (brolucizumab), covering 2017-09-29 to 2017-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration [Phase 2]